3J70 image
Deposition Date 2014-04-22
Release Date 2015-08-26
Last Version Date 2024-10-16
Entry Detail
PDB ID:
3J70
Title:
Model of gp120, including variable regions, in complex with CD4 and 17b
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
20.00 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:monoclonal antibody 17b light chain
Chain IDs:A, F (auth: M), K (auth: R)
Chain Length:212
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:monoclonal antibody 17b heavy chain
Chain IDs:B, G (auth: N), L (auth: S)
Chain Length:210
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:T-cell surface glycoprotein CD4
Gene (Uniprot):CD4
Chain IDs:C, H (auth: O), M (auth: T)
Chain Length:185
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp120
Gene (Uniprot):env
Chain IDs:D, I (auth: P), N (auth: U)
Chain Length:470
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:envelope glycoprotein gp41
Chain IDs:E, J (auth: Q), O (auth: V)
Chain Length:140
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Ligand Molecules
Primary Citation
Computational Refinement and Validation Protocol for Proteins with Large Variable Regions Applied to Model HIV Env Spike in CD4 and 17b Bound State.
Structure 23 1138 1149 (2015)
PMID: 26039348 DOI: 10.1016/j.str.2015.03.026

Abstact

Envelope glycoprotein gp120 of HIV-1 possesses several variable regions; their precise structure has been difficult to establish. We report a new model of gp120, in complex with antibodies CD4 and 17b, complete with its variable regions. The model was produced by a computational protocol that uses cryo-electron microscopy (EM) maps, atomic-resolution structures of the core, and information on binding interactions. Our model has excellent fit with EMD: 5020, is stereochemically and energetically favorable, and has the expected binding interfaces. Comparison of the ternary arrangement of the loops in this model with those bound to PGT122 and PGV04 suggested a possible motion of the V1V2 away from the CCR5 binding site and toward CD4. Our study also revealed that the CD4-bound state of the V1V2 loop is not optimal for gp120 bound with several neutralizing antibodies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures